NCT00715351View on ClinicalTrials.gov

Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes

CompletedOBSERVATIONAL
Enrollment

342

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

Physician decides which insulin should be prescribed, selection of subjects will be at the discretion of participating physician

DRUG

insulin NPH

Physician decides which insulin should be prescribed, selection of subjects will be at the discretion of participating physician

Trial Locations (1)

SI-1000

Novo Nordisk Investigational Site, Ljubljana

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00715351 - Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes | Biotech Hunter | Biotech Hunter